Pyrroloquinoline Quinone Disodium Salt

Why brands use Pyrroloquinoline Quinone Disodium Salt

Pyrroloquinoline Quinone Disodium Salt is a formulation input reviewed per project, sitting in the functional compounds family. On DAT Supply briefs the positioning is set by the brand brief and reviewed against the target market’s claim rules — we do not pre-position an active for any single benefit. Editorial framing uses only EU 432/2012- or DSHEA-compatible wording — we never promote unauthorised claims, even when the active has consumer-side momentum. Format-wise we have considered Pyrroloquinoline Quinone Disodium Salt for gummies, powder stick, jelly and strip; the per-format formulation notes below describe the live constraints (taste, payload, stability, packaging) we tune in the formulation pass. Sourcing form (extract ratio for botanicals, salt or chelate form for minerals, free-form vs ester for amino acids) is reviewed against the brief, with documentation matched to the target market’s import rules. Inclusion rate and claim wording are reviewed per project — we don’t publish off-the-shelf doses.

How we use Pyrroloquinoline Quinone Disodium Salt in formulas

A public-safe formulation reference — how this active behaves in our formats, common pairings and handling notes. Final formulation, dose and on-pack copy are confirmed per project.

Heat stable

Limited — use coated forms

Soluble in matrix

Conditional

Vegan supply

Project-specific

EU-authorised health claims

EU-authorised wording for this ingredient is reviewed per project against Reg. 1924/2006 and the authorised list under Reg. 432/2012. No final claim wording is implied by this page.

Pyrroloquinoline Quinone Disodium Salt is reviewed against the target market’s claim posture: EU 432/2012 wording (UK tracks EU post-Brexit) for the EU/UK route, and DSHEA structure-function wording with the FDA disclosure for the US route. Pack copy is rewritten per market and confirmed per project.